期刊文献+

CCR5基因多态性的研究进展 被引量:3

下载PDF
导出
出处 《实用医技杂志》 2007年第4期429-430,共2页 Journal of Practical Medical Techniques
  • 相关文献

参考文献5

二级参考文献30

  • 1王福生,中华性病艾滋病防治,2000年,6卷,5页
  • 2Lu Y,Int J Infect Dis,1999年,3卷,186页
  • 3Wang F S,J Chinese AIDS/STD Prevention Control,2000年,6卷,2期,64页
  • 4Lu Y,Int J Infect Dis,1999年,3卷,4期,186页
  • 5Zhang J K,中华流行病学杂志,1999年,20卷,4期,234页
  • 6Feng Y;Broder CC;Kennedy PE.查看详情,1996.
  • 7Hori T;Oka T;Hosoi M.查看详情,1998.
  • 8Peled A;Petit I;Kollet O.The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow.[J],1999(9).
  • 9Fauci AS.查看详情[J],1996.
  • 10Joannef B.查看详情,1996(09).

共引文献47

同被引文献29

  • 1王睿,张松,时立新.CCR5基因启动子多态性与2型糖尿病肾病相关性研究[J].贵州医药,2007,31(6):500-503. 被引量:2
  • 2蒲春文,姜春萌,丛树荣,马大鹏.细胞趋化因子受体CXCR3及CCR5在乙型肝炎患者肝组织中的表达[J].中华肝脏病杂志,2005,13(9):708-709. 被引量:11
  • 3Thio CL,Astemborski J,Bashirova A,Mosbruger T,Greer S,Witt MD,Goedert JJ,Hilgartner M,Majeske A,O'Brien SJ,Thomas DL,Carrington M.Genetic protection against hepatitis B virus conferred by CCR5Delta32:Evidence that CCR5 contributes to viral persistence.J Virol 2007; 81:441-445.
  • 4Samson M,Libert F,Doranz BJ,Rucker J,Liesnard C,Farber CM,Saragosti S,Lapoumeroulie C,Cognaux J,Forceille C,Muyldermans G,Verhofstede C,Burtonboy G,Georges M,Imai T,Rana S,Yi Y,Smyth RJ,Collman RG,Doms RW,Vassart G,Parmentier M.Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.Nature 1996; 382:722-725.
  • 5Shahbazi M,Ebadi H,Fathi D,Roshandel D,Mahamadhoseeni M,Rashidbaghan A,Mahammadi N,Mahammadi MR,Zamani M.CCR5-Delta32 Allele is Associated with the Risk of Developing Multiple Sclerosis in the Iranian Population.Cell Mol Neurobiol 2009 May 29.[Epub ahead of print].
  • 6Ajuebor MN,Aspinall AI,Zhou F,Le T,Yang Y,Urbanski SJ,Sidobre S,Kronenberg M,Hogaboam CM,Swain MG.Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1drestricted NKT cells.J Immunol 2005; 174:8027-8037.
  • 7Ahn SH,Kim do Y,Chang HY,Hong SP,Shin JS,Kim YS,Kim H,Kim JK,Paik YH,Lee KS,Chon CY,Moon YM,Han KH.Association of genetic variations in CCR5 and its ligand,RANTES with clearance of hepatitis B virus in Korea.J Med Virol 2006; 78:1564-1571.
  • 8Ioannidis JP,Rosenberg PS,Goedert JJ,Ashton LJ,Benfield TL,Buchbinder SP,Coutinho RA,Eugen-Olsen J,Gallart T,Katzenstein TL,Kostrikis LG,Kuipers H,Louie LG,Mallal SA,Margolick JB,Martinez OP,Meyer L,Michael NL,Operskalski E,Pantaleo G,Rizzardi GP,Schuitemaker H,Sheppard HW,Stewart GJ,Theodorou ID,Ullum H,Vicenzi E,Vlahov D,Wilkinson D,Workman C,Zagury JF,O'Brien TR; International Meta-Analysis of HIV Host Genetics.Effects of CCR5-Delta32,CCR2-64I,and SDF-1 3'A alleles on HIV-1 disease progression:An international meta-analysis of individual-patient data.Ann Intern Med 2001; 135:782-795.
  • 9Martinson JJ,Chapman NH,Rees DC,Liu YT,Clegg JB.Global distribution of the CCR5 gene 32-basepair deletion.Nat Genet 1997; 16:100-103.
  • 10石宏,郝大林,孙成学.CCR5阳性细胞CD30阳性细胞检测在乙型肝炎中的临床应用[J].中国实验诊断学,2007,11(8):1112-1114. 被引量:2

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部